Literature DB >> 6304353

Small deletion in src of Rous sarcoma virus modifying transformation phenotypes: identification of 207-nucleotide deletion and its smaller product with protein kinase activity.

N Kitamura, M Yoshida.   

Abstract

Partial deletion in the src gene and the gene product were characterized in a deletion mutant, dl5, isolated from the Prague strain of Rous sarcoma virus. The mutant induced fusiform-like transformed cells, unlike the parental Prague strain, which induced round transformed cells. Determination of the total nucleotide sequences of src in dl5 and the Prague strain of Rous sarcoma virus demonstrated that in the former two deletions of 196 and 11 nucleotides had occurred at positions 403 and 696, respectively, from the 5' end of src. A protein with a molecular weight of 52,000 (p52src) was detected in cells infected with dl5, as predicted from the deletion size in src. From the nucleotide sequence, it was predicted that p52src had two deletions of 65 and 4 amino acids at positions 135 and 232, respectively, from the N-terminal methionine of p60src and also had 33 amino acid changes between these two deletion sites due to alteration of the reading frame. p52src, which contained deletions and alterations of amino acids near the N-terminus, showed protein kinase activity similar to that of p60src and functioned in the infected cells. These results strongly suggest that changes in the N-terminal region of p60src modified its transforming ability, causing induction of the fusiform-like transformation phenotype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304353      PMCID: PMC256573     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Characterization of the avian sarcoma virus protein p60src.

Authors:  J S Brugge; P J Steinbaugh; R L Erikson
Journal:  Virology       Date:  1978-11       Impact factor: 3.616

3.  Improved derivative of a phage lambda EK2 vector for cloning recombinant DNA.

Authors:  D Tiemer; L Enquist; P Leder
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

4.  Identification of a transformation-specific antigen induced by an avian sarcoma virus.

Authors:  J S Brugge; R L Erikson
Journal:  Nature       Date:  1977-09-22       Impact factor: 49.962

5.  Protein kinase activity associated with the avian sarcoma virus src gene product.

Authors:  M S Collett; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  Transformation-defective mutants of Rous sarcoma virus with src gene deletions of varying length.

Authors:  S Kawai; P H Duesberg; H Hanafusa
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

7.  Induction of some transformation-related properties by a transformation-defective mutant of avian sarcoma virus.

Authors:  M Yoshida; Y Ikawa
Journal:  Virology       Date:  1977-12       Impact factor: 3.616

8.  Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA.

Authors:  P R Shank; S H Hughes; H J Kung; J E Majors; N Quintrell; R V Guntaka; J M Bishop; H E Varmus
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

9.  Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein.

Authors:  A D Levinson; H Oppermann; L Levintow; H E Varmus; J M Bishop
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

10.  Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes.

Authors:  J C Alwine; D J Kemp; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  25 in total

1.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

3.  Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.

Authors:  H Hirai; H E Varmus
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Deletions and insertions within an amino-terminal domain of pp60v-src inactivate transformation and modulate membrane stability.

Authors:  H C Wang; J T Parsons
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  The membrane-binding domain and myristylation of p60v-src are not essential for stimulation of cell proliferation.

Authors:  G Calothy; D Laugier; F R Cross; R Jove; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

6.  Correspondence between immunological and functional domains in the transforming protein of Fujinami sarcoma virus.

Authors:  J C Stone; T Pawson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

7.  Genetic analysis of p60v-src domains involved in the induction of different cell transformation parameters.

Authors:  R Jove; B J Mayer; H Iba; D Laugier; F Poirier; G Calothy; T Hanafusa; H Hanafusa
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  N-terminal deletions in Rous sarcoma virus p60src: effects on tyrosine kinase and biological activities and on recombination in tissue culture with the cellular src gene.

Authors:  F R Cross; E A Garber; H Hanafusa
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

9.  Deletions within the amino-terminal half of the c-src gene product that alter the functional activity of the protein.

Authors:  S P Nemeth; L G Fox; M DeMarco; J S Brugge
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

10.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells.

Authors:  S Tanaka; S Hattori; T Kurata; K Nagashima; Y Fukui; S Nakamura; M Matsuda
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.